SCHEMBL464938

SCHEMBL464938

CCCCCCCCCCCCCC(C)(c1cc(C(C)(C)C)c(O)cc1C)C(CCCCCCCCCCCCC)(CCCCCCCCCCCCC)C(CCCCCCCCCCCCC)(c1cc(C(C)(C)C)c(O)cc1C)c1cc(C(C)(C)C)c(O)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.42
TP53 P04637 2/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
HIF1A Q16665 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CNR1 P21554 10/20 0.36
CNR2 P34972 10/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
MAPT P10636 1/20 0.36
ATP2A2 P16615 1/20 0.36
ATP2A3 Q93084 1/20 0.36
ESR1 P03372 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1974575 0.96 ALOX15 (0.39) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL9579481 0.96 ALOX15 (0.39) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL1974579 0.96 ALOX15 (0.39) ALOX15TP53CYP2D6CYP2C9CYP2C19
Phosphoric Acid SCHEMBL17838070 0.94 TP53 (0.38) ALOX15TP53CYP2D6CYP2C9CYP2C19
Phosphoric Acid SCHEMBL17835464 0.94 TP53 (0.38) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL29486317 0.93 ALOX15 (0.37) ALOX15TP53CYP2D6CYP2C9CYP2C19
Pyrophosphoric Acid SCHEMBL17838071 0.90 TP53 (0.35) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL9579467 0.88 TP53 (0.34) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL17838069 0.83 TP53 (0.31) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL10883014 0.82 CNR1 (0.39) ALOX15TP53CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239736-A1 METHOD FOR PRODUCING METHYLENEMALONIC ACID ESTER NIPPON SHOKUBAI CO., LTD. (JP) 2024-07-18 US disclosed
WO-2024150527-A1 MOLDED ARTICLE, PRODUCTION METHOD FOR LASER-MARKED MOLDED ARTICLE, AND LASER MARKING METHOD 旭化成株式会社 2024-07-18 WO disclosed
EP-4400543-A1 THERMOPLASTIC RESIN COMPOSITION, METHOD FOR MANUFACTURING SAME, AND MOLDED ARTICLE COMPRISING SAME LG Chem, Ltd. (KR) 2024-07-17 EP disclosed
EP-4098697-B1 THERMOPLASTIC RESIN COMPOSITION, METHOD OF PREPARING THE SAME, AND MOLDED ARTICLE INCLUDING THE SAME LG CHEMICAL LTD (KR) 2024-07-10 EP disclosed
EP-4397709-A1 THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MOLDED ARTICLE INCLUDING SAME LG Chem, Ltd. (KR) 2024-07-10 EP disclosed
WO-2024128247-A1 RECTANGULAR WIRE AND PRODUCTION METHOD FOR SAME AGC株式会社 2024-06-20 WO disclosed
US-20240166813-A1 POLYAMIDE RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-05-23 US disclosed
WO-2024101220-A1 CURABLE RESIN COMPOSITION AND FILM 住友化学株式会社 2024-05-16 WO disclosed
WO-2024085398-A1 THERMOPLASTIC RESIN COMPOSITION, METHOD FOR MANUFACTURING SAME, AND MOLDED ARTICLE COMPRISING SAME (주) 엘지화학 2024-04-25 WO disclosed
WO-2024085404-A1 THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MOLDED ARTICLE INCLUDING SAME (주) 엘지화학 2024-04-25 WO disclosed
US-5015612-A Titanium-Magnesium Component, Organoaluminum Compound, Electron Donor MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-05-14 US disclosed
EP-0423346-A1 CYCLOOLEFINIC RESIN COMPOSITION MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-04-24 EP disclosed
EP-0399439-A2 Laminate and process for producing the same SHOWA DENKO KABUSHIKI KAISHA (JP) 1990-11-28 EP disclosed
EP-0343863-A2 Ultra-high-molecular-weight polyolefin composition MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1989-11-29 EP disclosed
EP-0203799-A1 Random copolymer and process for production thereof MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1986-12-03 EP disclosed
US-4614778-A ETHYLENE AND A 1,4,5,8-DIMETHANG-1,2,3,4,4A,5,8,8A-OCTAHYDRONAPHTHALENE MITSUI CHEMICALS, INC. (JP) 1986-09-30 US disclosed
EP-0168721-A1 Compositions containing organic phosphite esters having improved resistance to hydrolysis in the presence of water ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1986-01-22 EP disclosed
EP-0156464-A1 Random copolymer MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1985-10-02 EP disclosed
US-4243581-A A POLYVINYL PHENOL, A DIALKYLTHIODIPROPIONATE, OXIDATION RESISTANCE MARUZEN OIL CO., LTD. (JP) 1981-01-06 US disclosed
US-4221700-A POLY(ALKYLATED ALKENYLPHENOL); POLYESTERS OF ALKYLTHIOALKANOIC ACIDS OR ORGANIC PHOSPHITE MARUZEN OIL CO., LTD. (JP) 1980-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239736-A1 METHOD FOR PRODUCING METHYLENEMALONIC ACID ESTER MPST, ME1, ME3 ALOX15 555/4885TP53 4332/4885CYP2D6 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.